IG
CANO

Inherent Group’s Cano Health, Inc. CANO Stock Holding History

Inherent Group’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,035
Closed -$6.27M – 55
2021
Q4 		$6.27M Sell
7,035
-9,927
-59% -$10.4M 1.07% 26
2021
Q3 		$21.5M Buy
16,962
+3,800
+29% +$4.61M 1.86% 10
2021
Q2 		$15.9M Buy
13,162
+5,358
+69% +$7.23M 1.46% 12
2021
Q1 		$10.3M Buy
+7,804
New +$11M 1.46% 16

Other funds holding CANO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Inherent Group's CANO Position: Q1 2022 in Review

Inherent Group sold out of Cano Health, Inc. (CANO) in Q1 2022, closing a stake of 7,035 shares — an estimated $6.27M sold.

Inherent Group first reported a position in CANO in Q1 2021 and held it in 4 quarters. The position peaked at $21.5M in Q3 2021. 146 funds tracked by Wall St. Rank hold CANO as of Q1 2022.

  • Inherent Group reported no remaining Cano Health, Inc. position as of Q1 2022 after selling out during the quarter.
  • Inherent Group sold 7,035 Cano Health, Inc. shares in Q1 2022, an estimated $6.27M.
  • Inherent Group first reported a position in Cano Health, Inc. in Q1 2021 and held it in 4 quarters.
  • Inherent Group's Cano Health, Inc. position peaked at $21.5M in Q3 2021.
  • 146 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2022.

Based on Inherent Group's 13F filing for Q1 2022, filed 16 May 2022.